A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma

Reporting results of cancer treatment

1981 • 7,916 citations

National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

1982 • 3,027 citations

Toxicity of E. coli L-asparaginase in man

1970 • 290 citations

Toxicity of L-asparaginase in children with advanced leukemia

1972 • 187 citations

L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies

1971 • 181 citations

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

1970 • 172 citations

Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.

1979 • 128 citations

L-Asparaginase

1970 • 117 citations

Cyclic combination chemotherapy of canine lymphosarcoma.

1981 • 93 citations

Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.

1987 • 88 citations

The effect of L-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia

1977 • 85 citations

Treatment of lymphosarcoma in the dog with L-asparaginase

1967 • 73 citations

Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.

1979 • 45 citations

A preliminary study on the evaluation of asparaginase. Polyethylene glycol conjugate against canine malignant lymphoma

1987 • 39 citations

Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice.

1982 • 23 citations